Therabest is a biopharmaceutical company that develops iPSC-derived immune cells. Our mission is to provide the benefits of cell therapy to many patients. We established a robust process that manufacture Armored iPSC CAR-NK, off-the-shelf cell products using our exclusive technology. Currently, our main pipeline is CD19 (Lymphoid tumor) and Muc1c (Solid tumor). We plan to expand our pipeline through collaboration with companies that own tumor target scFv.
| Website | http://therabest.co.kr/kr/ |
| Employees | 13 (10 on RocketReach) |
| Founded | 2012 |
| Industry | Biotechnology Research |
| Keywords | Cell Therapy, Cell Therapies, Immune Cell Therapy, Biopharmaceutical, Biotechnology, Regenerative Medicine, Clinical Trials, Off The Shelf Therapy, Pharmaceutical, Cell Manufacturing, Drug Development, Immunotherapy, Healthcare, Oncology, Cancer Treatment |
| Competitors | Thermo Fisher Scientific, Sartorius, Corning Incorporated, Eppendorf Group, PerkinElmer, Inc., VWR, part of Avantor, Agilent Technologies, GE HealthCare, Merck Group, Waters Corporation +46 more (view full list) |
Looking for a particular Therabest employee's phone or email?
Therabest Questions
Sung Lee is the Chief Development Officer (CDO) of Therabest.
10 people are employed at Therabest.
Top Therabest Employees
-
Sung Lee
Chief Development Officer (CDO) at Therabest
California, United States25 -
Youngbae Shin
CFO at Therabest
Seoul, KR -
Sungkuk Park
Chief Business Development Officer at Therabest
Gyeonggi-do, South Korea -
Minchul Kim
Researcher at Therabest
Yongin-si, KR11 -
Yoosung Kim
Scientific Researcher at Therabest
Gyeonggi-do, South Korea -
Yeeun Park
연구원 at Therabest
Toronto, ON, CA1 -
Yunjung Park
Quality Assurance Lead at Therabest
Gyeonggi-do, South Korea
Related Companies
G2Crowd Trusted
300K+
Plugin Users
